InsidersTradesSigma
Follow the POLYNOVO LIMITED stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on AU AU, under the supervision of ASX. Market capitalisation: €639m. The latest transaction was filed on 23 June 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. All data is free.
Analysts rate POLYNOVO LIMITED Strong Buy (bullish), based on 8 analysts. Average price target: A$1.70.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
POLYNOVO LIMITED is an Australian Securities Exchange listed company focused on developing innovative medical devices. It primarily concentrates on wound care solutions and biomaterial implants.